Jennifer Gribble, PhD

Jennifer graduated from Iowa State University with a B.S. in biochemistry.  As an undergraduate, she studied the epigenetics of metabolic disorders in Drosophila melanogaster at Iowa State under Dr. Kristen Johansen, the role of gut microbiotic diversity in malarial infection as a part of an NSF REU at the University of Tennessee, and inflammatory signaling in the bone marrow at Boston Children's Hospital though the Harvard Amgen Program.  She then joined the Vanderbilt IGP and subsequently the Denison lab in 2017, where she subsequently developed a bioinformatics pipeline for studying coronaviruses and their recombination. She successfully defended her thesis on the determinants and outcomes of coronavirus recombination on December 7th, 2021. She is now a Bioinformatician III at Integrated DNA Technologies (IDT) in Coralville, Iowa.